Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1999;30:1577-1582

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pereira, A. C.
Right arrow Articles by Brown, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pereira, A. C.
Right arrow Articles by Brown, M. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-ASPARTIC ACID
Medline Plus Health Information
*MRI Scans
Related Collections
Right arrow Acute Cerebral Infarction
Right arrow Computerized tomography and Magnetic Resonance Imaging
Right arrow PET and SPECT

(Stroke. 1999;30:1577-1582.)
© 1999 American Heart Association, Inc.


Original Contributions

Measurement of Initial N-Acetyl Aspartate Concentration by Magnetic Resonance Spectroscopy and Initial Infarct Volume by MRI Predicts Outcome in Patients With Middle Cerebral Artery Territory Infarction

Anthony C. Pereira, MB, BChir; Dawn E. Saunders, MD; Victoria L. Doyle, PhD; J. Martin Bland, PhD; Franklyn A. Howe, DPhil; John R. Griffiths, DPhil Martin M. Brown, MD

From the Division of Clinical Neuroscience (A.C.P.), CRC Biomedical Magnetic Resonance Research Group (V.L.D., F.A.H., J.R.G.), and Department of Public Health Medicine (J.M.B.), St George's Hospital Medical School; Department of Radiology (D.E.S.), King's College Hospital; and Institute of Neurology, University College (M.M.B.), London, UK.

Correspondence to Dr Anthony C. Pereira, c/o Prof Martin Brown, Institute of Neurology, Queen Square, London, WC1N 3BG, England. E-mail m.brown{at}ion.ucl.ac.uk

Background and Purpose1H MR spectroscopy can be used to study biochemical changes occurring in the brain in stroke. We used it to examine the relationship between metabolite concentration (N-acetyl aspartate [NAA], lactate, cholines and creatines), size of infarct, clinical deficit, and 3-month clinical outcome in patients with middle cerebral artery (MCA) territory infarction.

Methods—Thirty-one patients with acute MCA territory infarction were recruited within 72 hours of the onset of symptoms. Single-voxel short echo time stimulated echo acquistion mode spectroscopy was used to obtain metabolite data from the infarct core. Metabolite concentrations were determined with use of variable projection time domain-fitting analysis. Infarct size was determined with T2-weighted images. Patient outcome groups at 3 months were "independent," "dependent," or "dead."

Results—All patients (100%; 95% CI 75% to 100%) who had an infarct >70 mL did poorly. Eighteen of 20 patients (90%; 95% CI 68% to 99%) with a core NAA concentration <7 mmol/L did poorly at 3 months, whereas 7 of 11 patients (64%; 95% CI 31% to 89%) with an initial NAA concentration >7 mmol/L did well. Combining these results showed that all patients who had an initial infarct volume >70 mL did poorly, irrespective of the NAA concentration. Of those patients with infarcts <70 mL, those who had a core NAA concentration >7 mmol/L did well (88%; 95% CI 47% to 100%), whereas those with a lower NAA concentration did poorly (80%; 95% CI 44% to 97%). There was no association between other metabolite concentrations and outcome.

Conclusions—Infarct volume and NAA concentration can together predict clinical outcome in MCA infarction in humans.


Key Words: human • outcome • spectroscopy, nuclear magnetic resonance • stroke




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
A.L. Coon, F. Arias-Mendoza, G.P. Colby, J. Cruz-Lobo, J. Mocco, W.J. Mack, R.J. Komotar, T.R. Brown, and E.S. Connolly Jr.
Correlation of Cerebral Metabolites with Functional Outcome in Experimental Primate Stroke Using in Vivo 1H-Magnetic Resonance Spectroscopy.
AJNR Am. J. Neuroradiol., May 1, 2006; 27(5): 1053 - 1058.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. D. Lindner, V. K. Gribkoff, N. A. Donlan, and T. A. Jones
Long-Lasting Functional Disabilities in Middle-Aged Rats with Small Cerebral Infarcts
J. Neurosci., November 26, 2003; 23(34): 10913 - 10922.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
S.-H. Oh, J.-G. Lee, S.-J. Na, J.-H. Park, Y.-C. Choi, and W.-J. Kim
Prediction of Early Clinical Severity and Extent of Neuronal Damage in Anterior-Circulation Infarction Using the Initial Serum Neuron-Specific Enolase Level
Arch Neurol, January 1, 2003; 60(1): 37 - 41.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. R. Malloy
Correlation of Cerebral Metabolites With Clinical Outcome Among Patients With Severe Congestive Heart Failure
Circulation, June 12, 2001; 103(23): 2771 - 2772.
[Full Text] [PDF]


Home page
Arch NeurolHome page
R. L. Levine
One-Stop Shopping: Stroke Questions Further Answered With Magnetic Resonance Imaging
Arch Neurol, April 1, 2001; 58(4): 555 - 556.
[Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
A C Pereira, P J Martin, and E A Warburton
Thrombolysis in acute ischaemic stroke
Postgrad. Med. J., March 1, 2001; 77(905): 166 - 171.
[Full Text]


Home page
StrokeHome page
C. J. M. Klijn, L. J. Kappelle, J. van der Grond, A. Algra, C. A. F. Tulleken, and J. van Gijn
Magnetic Resonance Techniques for the Identification of Patients With Symptomatic Carotid Artery Occlusion at High Risk of Cerebral Ischemic Events
Stroke, December 1, 2000; 31(12): 3001 - 3007.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
V. N. Thijs, M. G. Lansberg, C. Beaulieu, M. P. Marks, M. E. Moseley, and G. W. Albers
Is Early Ischemic Lesion Volume on Diffusion-Weighted Imaging an Independent Predictor of Stroke Outcome? : A Multivariable Analysis
Stroke, November 1, 2000; 31(11): 2597 - 2602.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. W. Parsons, T. Li, P. A. Barber, Q. Yang, D. G. Darby, P. M. Desmond, R. P. Gerraty, B. M. Tress, and S. M. Davis
Combined 1H MR spectroscopy and diffusion-weighted MRI improves the prediction of stroke outcome
Neurology, August 22, 2000; 55(4): 498 - 506.
[Abstract] [Full Text] [PDF]